Current Hematologic Malignancy Reports
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherCURRENT MEDICINE GROUP
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year2005
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Current Hematologic Malignancy Reports been publishing? 
The Current Hematologic Malignancy Reports has been publishing since 2005 till date.
How frequently is the Current Hematologic Malignancy Reports published?
Current Hematologic Malignancy Reports is published Quarterly.
What is the H-index. SNIP score, Citescore and SJR of Current Hematologic Malignancy Reports?
Current Hematologic Malignancy Reports has a H-index score of 40, Citescore of 6.5, SNIP score of 1.27, & SJR of Q2
Who is the publisher of Current Hematologic Malignancy Reports?
The publisher of Current Hematologic Malignancy Reports is CURRENT MEDICINE GROUP.
How can I view the journal metrics of Current Hematologic Malignancy Reports on editage?
For the Current Hematologic Malignancy Reports metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Current Hematologic Malignancy Reports?
The eISSN number is 1558-822X and pISSN number is 1558-8211 for Current Hematologic Malignancy Reports.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding B-cell lymphoma, Immunotherapy, Minimal residual disease, Monoclonal antibody, Diffuse large B-cell lymphoma, Toxicity, Chimeric antigen receptor, Hematopoietic stem cell transplantation, Cell therapy, Bispecific antibody, Hematology clinic, Chemoimmunotherapy, Chronic myelomonocytic leukemia, Bortezomib, Social media, T-cell lymphoma, Immune system, Myelofibrosis, Target antigen, Toxicity profile.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.